Specifically, YY1, functioning as a transcription factor, directly amplifies the expression of GALNT16, a glycosyltransferase, thereby enhancing PD‐L1 glycosylation in liver cancer cells and curbing PD‐L1 degradation via the ubiquitination pathway. The gene discussed is GALNT16; the disease is liver cancer.